Chris J. Stern
2011
In 2011, Chris J. Stern earned a total compensation of $469.7K as Chairman and Chief Executive Officer at Tenax Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,980 |
|---|---|
| Salary | $300,000 |
| Stock Awards | $29,113 |
| Other | $9,600 |
| Total | $469,693 |
Stern received $300K in salary, accounting for 64% of the total pay in 2011.
Stern also received $131K in non-equity incentive plan, $29.1K in stock awards and $9.6K in other compensation.
Rankings
In 2011, Chris J. Stern's compensation ranked 8,253rd out of 10,747 executives tracked by ExecPay. In other words, Stern earned more than 23.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,253 out of 10,747 | 23rd |
Division Manufacturing | 3,040 out of 3,960 | 23rd |
Major group Chemicals And Allied Products | 758 out of 1,033 | 27th |
Industry group Drugs | 546 out of 781 | 30th |
Industry Pharmaceutical Preparations | 422 out of 571 | 26th |
Source: SEC filing on September 6, 2011.
Stern's colleagues
We found three more compensation records of executives who worked with Chris J. Stern at Tenax Therapeutics in 2011.